* Global pharmaceutical market to grow 4%: report Oct 9, 2009
The worldwide pharmaceutical market will grow between 4 percent and 6 percent next year, exceeding US$825 billion, as more Americans get health insurance to pay for their prescriptions, a report from IMS Health Inc has found. Global growth will be between 4 percent and 7 percent each year through 2013, the report released yesterday from the Norwalk, Connecticut-based market research firm said. (Taipei Times, Taiwan -- World)
Study: Global Prescription Drug Sales Growth Slows Oct 8, 2009
IMS Health, which tracks sales of prescription drugs in 220 countries, cited increased sales of generic drugs, the global recession and other factors. In the United States, growth is expected to be about 5 percent, an improvement from last year, according to a five-year forecast from IMS. But that's up from the research firm's estimates from just several months ago, and the new estimates indicate global prescription drug sales could hit $1 trillion per year in 2013. (ABC News -- Wire)
IMS sees brighter outlook for global drug sales Oct 8, 2009
While growth through 2013 is still expected to be anemic compared to years past, the 2009 performance has led IMS Health (RX.N) to project a somewhat rosier outlook than it did in April. Just six months ago, IMS forecast 2009 U.S. prescription drug sales would decline for the first time since it started tracking the data in 1957, by 1 to 2 percent. (Yahoo News -- Pharmaceutical Industry News)
Sandoz Will Sell More Drugs in Japan, May Buy Companies, CEO George Says Oct 6, 2009
Generics made up 18 percent of drug sales volume in Japan in the year to March 31, while IMS Health Inc. estimates that such medicines account for about 63 percent of drugs prescribed in the U.S.. From the emerging markets perspective, there are a number of markets where we dont have the presence we would like to have, George said. (Bloomberg -- Japan)
FDA: New OxyContin would be harder to abuse Sep 25, 2009
3 billion, according to medical research firm IMS Health. The drug accounts for more than half the market for codeine-derived drugs, which also includes Vicodin and various generic medications. (MSNBC -- Health)
* A paradox in the market for cancer drugs Sep 21, 2009
3 percent, more than twice the overall industry average, according to research firm IMS Health. With hundreds of new drugs in development, cancer is a top priority for drugmakers including Pfizer, AstraZeneca, Roche, Novartis, GlaxoSmithKline and Sanofi-Aventis, all of whom are busy incorporating diagnostic biomarkers into their drug trials. (Taipei Times, Taiwan -- World Business)
Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118 Sep 14, 2009
According to IMS Health, about 230 million prescriptions were written for opioids in 2007 in the United States alone. Currently, there are no oral drugs approved that are indicated to treat opioid-induced constipation (OIC). (PR Newswire)
ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies Sep 9, 2009
Based on data from IMS Health, in 2008 approximately 6. 6 million prescriptions were filled for ocular allergy treatments, resulting in sales of approximately $560 million. (PR Newswire)
Opportunities in the Obesity Epidemic Sep 2, 2009
"Lifestyle modification only gets you so far when you are already obese," says Brian Lasky, consultant with drug market researcher IMS Health. "It's very hard to reboot the body on your own. Better drugs are essential." The market for drugs that treat obesity complications should be worth billions, he says. (BusinessWeek)
SDI to build new corporate HQ Aug 29, 2009
The company, which considers IMS Health its biggest competitor, collects and analyzes data from health-care and biotechnology companies. It looked at sites in Plymouth Meeting and Fort Washington, deciding to locate less than a mile from its current location. (Philadelphia Business Journal, PA)
Depressionomics Aug 28, 2009
About 164 million antidepressant prescriptions were written in 2008, 4 million more than in 2007, according to IMS Health, a health care information and consulting company. Antidepressants were the third most prescribed drug in 2008, hitting $9. (Slate)
Par Pharmaceutical & Aveva Drug Delivery Systems Receive Final Approval to Market Generic Catapres TTS(R) Aug 19, 2009
Annual U.S. sales of Catapres TTS((R)) were approximately $297 million, according to IMS Health data. Par will begin shipping clonidine TDS to the trade in the near future. (PR Newswire)
FDA backs limited use of Amgen bone drug Aug 15, 2009
s Fosamax, according to data from IMS Health. Analysts have estimated peak denosumab sales between $1 billion and $2 billion. (AZCentral -- Business)
Big drug firms embrace generics: Friends for life Aug 12, 2009
According to IMS Health, another consultancy, the seven biggest emerging markets will account for more than half of the industry s total sales growth this year. By 2012, it reckons, nine of the top 20 markets will be emerging economies. (The Economist)
New bone drug can cut fracture risk in elderly Aug 12, 2009
4 billion last year, according to data from IMS Health. About 10 million Americans have osteoporosis. (MSNBC -- Health)
Takeda Leads Japan Drugmakers' Revenue Drop as Stronger Yen Hurts Earnings Aug 1, 2009
Drugmakers worldwide will generate $70 billion less in revenue this year than previously estimated as consumers cut spending and currency fluctuations hurt overseas sales, IMS Health Inc., a Nowalk, Conneticut-based research company, said on April 22. Japans drugmakers are expanding abroad and making acquisitions to reduce reliance on their home market, where government-mandated price cuts for prescription medicines take place every two years. (Bloomberg -- Japan)
2nd Circuit: Hacker Can Be Sued for Fraud Under Securities Act Jul 24, 2009
Ukranian national Oleksandt Dorozhko invested $42,500 through his online trading account in October 2007 and spent almost all of it on "put" options in IMS Health, Inc., betting the company's quarterly earnings would disappoint and the stock price would drop. IMS Health Inc., which had hired Thomson Financial Inc. to provide investor relations and Web-hosting services, was set to announce earnings on Oct. 17, 2007, at 5 p.m. ... They also allege he was the one who hacked into Thomas Financial's... (Law.com)
Stalemated Vanda Needs Buyout or Partner to Launch Drug for Schizophrenia Jul 23, 2009
The category had almost $23 billion in global sales last year, according to IMS Health Inc. in Norwalk, Connecticut. While Fanapt resembles other drugs, patients often switch products and give newcomers a chance for sales. (Bloomberg -- US)
Double Helix Strengthens its Strategic Pricing and Reimbursement Practice with Hire of Caryn Zieses Jul 21, 2009
Zieses joins the Double Helix Consulting US team from the Pricing & Reimbursement consulting practice of IMS Health. She has worked closely with both large and small pharmaceutical and biotech clients to deliver global strategic recommendations that would inform decisions related to drug pricing, market access, clinical trial design, value messaging, payer attitudes, forecasting, and commercial assessments. (PR Newswire)
Robert Louis-Dreyfus, 63, master of the turnaround Jul 17, 2009
By 1982, he left Louis Dreyfus SAS to join what is now called IMS Health Inc., a market research firm for the pharmaceutical industry. In an interview with Fortune magazine in 1997, he said he had initially joined the IMS board because he lost a bet to a wealthy friend. (Boston Globe)
Amgen's Uphill Marketing Battle Jul 9, 2009
6 billion in sales in 2007, according to IMS Health (). Total sales dropped 22% last year when cheap versions of Fosamax became available. (BusinessWeek)
INSOMNIA: Fueling drug sales Jul 7, 2009
About 42 million were filled in 2005, according to research company IMS Health, up 60% from 2000. Though barbiturates were employed to soothe insomniacs in the '50s and '60s, they had serious side effects, including addiction. (USA Today -- Tech)
Popularity of brain-boost pills drives debate Jul 5, 2009
In 2008, more than 9 million prescriptions were filled for the drug, according to research firm IMS Health. An additional 927,000 prescriptions were filled for Ritalin, which also is used to treat attention deficit disabilities. (AZCentral)
Highlights: Stocks slump ... stimulus package ... Jul 4, 2009
IMS Health, which provides market research to the pharmaceutical and health care industries, said Friday that it will cut 10 percent of jobs worldwide by the end of the year. The company said it expects to take a pretax charge of 86 million to 90 million in the fourth quarter of 2007, mostly for job termination benefits. (La Crosse Tribune, WI)
Experts Urge Stronger Limits for Some Pain Drugs Jul 2, 2009
6 billion in 2008, according to IMS Health. Nearly 80 percent of that is from combination products sold directly to consumers. (MEDLINEplus)
FDA Panel: Eliminate Vicodin, Similar Drugs Jul 1, 2009
6 billion last year, with 80 percent of the market comprised of over-the-counter products, according to IMS Health, a health care analysis firm. 2009 Associated Press. (Newsmax)
Click to read:FDA Panel Sounds Alarm On Painkiller Doses Jul 1, 2009
6 billion last year, with 80 percent of the market comprised of over-the-counter products, according to IMS Health, a health care analysis firm. "The acetaminophen people dodged a bullet," said Erik Gordon, a University of Michigan business professor who studies the biomedical industry. (CBS News)
Justice Souter's last hurrah Jul 1, 2009
IMS Health Inc. Verispan LLC claimed wanted to collect, analyze and sell prescription information to drug marketers. - Refused to hear arguments from Missouri officials who want to restrict protests near funerals. (Casa Grande Valley Newspapers, AZ)
Panel backs painkiller limits Jul 1, 2009
The 500-milligram tablets account for more than 90 percent of US sales of single-ingredient acetaminophen, according to an FDA review of data from IMS Health. Almost 25 billion doses of the drug were sold in 2008. (Boston Globe)
Marcial: Generic Lipitor Prospects Spur Watson Pharma Jul 1, 2009
6 billion last year, according to drug research group IMS Health (). The combined Watson/Arrow companies (the purchase will close in the second half of 2009) will produce about $3. (BusinessWeek)
FDA Panel: Maximum Dose for Tylenol, Pain Relievers Should be Reduced to Curb Deadly Overdoses Jul 1, 2009
6 billion last year, with 80 percent of the market comprised of over-the-counter products, according to IMS Health, a health care analysis firm. "We believe there is a clear health benefit of over-the-counter combination products containing acetaminophen," Linda Suydam, the group's president, said Monday. (Fox News)
Court Rules For Firefighters In Ricci Case Jun 30, 2009
The high court on Monday refused to hear an appeal from IMS Health Inc., of Norwalk, Conn. and Verispan LLC, of Yardley, Pa. (CBS News)
The Jackson factor Jun 30, 2009
2 million prescriptions dispensed for antidepressants in 2008, compared to 143 million in 2004, according to IMS Health, a healthcare information company ... 6 billion, says IMS HEALTH. USA Today, June 3, 2009. (Asia Times Online)
BUSINESS PEOPLE Jun 28, 2009
Search Local Business Listings. Community NewsCommunity news on families, living & more from The Times of Trenton. (NJ.com -- Times)
Prescription drug fight goes before appeals court Jun 24, 2009
Julin, representing IMS Health Inc., Verispan LLC and Source Healthcare Analytics Inc., told the judges that information gathered by the companies is noncommercial speech protected by the First Amendment. He said the companies are the world's leading publishers of information regarding the pharmaceutical and health care industries. (Fresno Bee -- Nation)
America's Medicated Army Jun 23, 2009
In 2004, the last year for which complete data for the U.S. are available, doctors wrote 147 million prescriptions for antidepressants, according to IMS Health, a pharmaceutical-market-research firm. This number reflects in part the common practice of cycling through different medications to find the most effective drug. (Time.com)
'Data mining' for drug companies goes to courts Jun 20, 2009
Randy Frankel, vice president for external affairs at IMS Health, said restricting the ability of his and similar companies to collect doctors' prescribing data could hurt more than just commercial activity ... The data companies, IMS Health Inc. and SDI, argue that restricting the data collection and use violates their and the drug companies' First Amendment free speech rights to collect and use the information. (Concord Monitor)
New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development Jun 18, 2009
The report was commissioned by ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, and developed by IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries ... ICON commissioned IMS Health to conduct a survey that explored global trends in drug safety issues, and to evaluate the impact of recent safety regulations on the industry. (PR Newswire)
Torax Medical gets $18M for reflux-fighting med-tech device Jun 17, 2009
-based IMS Health Inc.. Drugs are a starting point, but they don t fix the defect, Berg said. (Twin Cities Business Journal, MN)
FDA to parents: Don't toss ADHD drugs Jun 16, 2009
8 billion last year, according to health care analysis firm IMS Health. The most popular brands include Shire's Adderall, Johnson & Johnson's Concerta and Novartis' Ritalin. (MSNBC -- Health)
FDA panel OKs 3 psychiatric drugs for kids Jun 16, 2009
6 billion, according to health care analysis firm IMS Health ... 6 billion in sales, according to IMS Health. (MSNBC -- Health)
Psychiatric Drugs For Kids Scrutinized Jun 6, 2009
4 billion last year, according to IMS Health. FDA reviewers on Friday said they were wary of exposing youngsters to the drugs' side effects, including weight gain and high blood sugar, "because they may be exposed for many decades.". (CBS News)
Drugmakers vie for lucrative diabetes market Jun 6, 2009
3 billion last year, making them the No. 4 class, according to IMS Health. "We need innovation in detecting and monitoring diabetes, in therapeutic effectiveness and in convenience of administering treatment," said Erik Gordon, an analyst and professor at the University of Michigan's Ross School of Business. (MSNBC -- Health)
Conflicts of interest bedevil psychiatric drug research Jun 3, 2009
6 billion, says IMS HEALTH. ... 6 billion, says IMS HEALTH.. (USA Today -- News)
Novexel to Present Four Posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases in Helsinki May 18, 2009
1] Source: IMS Health, MIDAS, 2006-2008 For further information please contact: Novexel Gordon Waldron, CFO Citigate Dewe Rogerson Amber Bielecka/David Dible/Nina Enegren Tel. 44-207-638-95-71. (PR Newswire)
Pfizer offers free drugs for unemployed May 15, 2009
Patients have been switching from brand-name drugs to generic copies that cost a fraction of the price, according to IMS Health, a research company based in Norwalk, Connecticut. Generic Zocor. (Sydney Morning Herald -- Business)
Which doctors lead the way? May 14, 2009
Health information companies IMS Health and SDI Health in March filed a petition to appeal a 3-year-old New Hampshire ban on the commercial use of doctors' prescribing information ... Other firms, including IMS Health and Wolters Kluwer, which also assisted in the influential doctors list, package similar information ... Cindy Rosenwald, chairwoman of the state's health committee, worried so much about the commercial use of prescribing data that in 2006 she persuaded her fellow legislators to... (USA Today)
Report: Drug sales down in US, slower elsewhere Apr 28, 2009
The forecast by data firm IMS Health is a big sign that an industry long considered recession-proof is feeling the effects of the global slowdown. IMS, which tracks medication sales in more than 100 countries, said Wednesday it expects a growth rate of 2. (Yahoo News -- Pharmaceutical Industry News)
Glaxo and Pfizer create new HIV drug company Apr 17, 2009
3 billion last year, according to data firm IMS Health. The companies said their revenues will provide the new company with financial stability and fund research and development, which it will contract directly from Glaxo and Pfizer. (Yahoo News -- Pharmaceutical Industry News)
Economic woes leave diabetics skimping on care, risking lives Apr 13, 2009
Sales of the most widely used pill, $4-a-month metformin, are up 7% since June, according to the AP analysis of figures from health data firm IMS Health Inc. Brand-name versions of the same drug, costing 10 times as much, are down 9%, on average, since then ... That could mean some patients would rather face a needle to save money, according to Brian Lasky, a research analyst at IMS Health. (USA Today -- News)
Talk therapy helps older adults Apr 8, 2009
6 billion in U.S. sales, according to IMS Health. Text. (India Times, India)
Allergic Reactions To Plavix Can Be Treated With Steroids And Antihistamines, Study Shows Apr 8, 2009
Data from 2007 shows Plavix is the fourth most sold drug in the United States with almost four billion dollars in sales, according to IMS Health, a leading pharmaceutical industry monitoring company. It is estimated that about six percent of those taking the drug showed some signs of an allergic reaction. (Science Daily)
Medicos to assist IT firms Mar 30, 2009
According to IMS Health, a consultancy firm, the global life sciences market will be as large as $830 billion in 2009. These companies typically spend 3-5% of their total revenue on IT which includes both hardware and software. (India Times)
Data Mining Case Heads to the Supreme Court Mar 28, 2009
The petition, titled IMS Health, Inc. and Verispan LLC v. Ayotte, is an appeal of a controversial ruling last November by the 1st U.S. Circuit Court of Appeals. The appeals panel ruled that the data about drug prescriptions gathered by the companies is outside the protection of the First Amendment, in part because it has "scant societal value," in the same way that obscenity is not protected speech. (Law.com)
NH prescription privacy law at high court Mar 28, 2009
In an appeal filed Friday, IMS Health Inc., of Norwalk, Conn. and Verispan LLC, of Yardley, Pa. (Concord Monitor)
State Capitol Briefs, Thursday, March 26 Mar 28, 2009
By State House News Service. Thu Mar 26, 2009, 05:20 PM EDT. (Belmont Citizen Herald, MA)
Prescription sales rise by $1.2-billion, even as generics gain popularity Mar 27, 2009
2-billion from the previous year, according to data published by IMS Health, a private company that tracks prescription drug sales ... The data from IMS Health reveal that, for the first time, the majority of drugs dispensed in Canada - 51. (Globe and Mail -- Business)
Mylan sued over drug patent challenges Mar 27, 2009
4 billion last year, according to IMS Health. Drug patents typically last 17 years, but patent challenges can extend that period another 30 months. (Pittsburgh Business Times, PA)
US drug sales growth continues slowdown in 2008 Mar 23, 2009
NEW YORK Sales growth of prescription drugs in the U.S. slowed for the second straight year, with the economic downturn playing a key role, according to IMS Health Inc.. Market research firm IMS cites lower demand for less-expensive generic drugs, lagging new product sales, and reduced consumer demand. (Yahoo News -- Pharmaceutical Industry News)
Eli Lilly & Co. heads CalPERS' watch list Mar 20, 2009
And CalPERS is critical of IMS Health for not allowing shareholders to call for special meetings or non-binding advisory votes. The Norwalk, Conn. (Sacramento Business Journal, CA)
IMS CEO Got $5.9M Compensation Package in 2008 Mar 14, 2009
IMS Health CEO David Carlucci received compensation package worth $5 ... David Carlucci, the chief executive of IMS Health Inc., received a compensation package worth $5. (ABC News -- Wire)
The top 10 drugmakers by sales Mar 10, 2009
Largest drugmakers by 2008 pharmaceutical sales, according to estimates by data company IMS Health. The figures exclude medical devices, animal health products and some consumer health products. (Yahoo News -- Pharmaceutical Industry News)
Sleeping in a bad economy Mar 9, 2009
But for those who need more - and many do; doctors wrote more than 56 million prescriptions in 2008, according to IMS Health, a healthcare information company - sleeping pills are an acceptable alternative. What changed. (Boston Globe)
Analysts see P&G Pharma as tough pill to swallow Mar 2, 2009
1 billion in sales, has seen its U.S. market share decline to 29 percent in December from 36 percent in September 2005, according to Bernstein research, using data from IMS Health. At the same time, sales of rival drug Boniva, as well as generic drugs, rose. (Cincinnati Business Courier, OH)
Genentech Provokes Doctor's Ire With Cost-Doubling Avastin Cancer Research Feb 26, 2009
Cancer-fighting medicines generated in global sales in 2007, making them the top-selling drug group, according to research firm IMS Health Inc. Avastins cost, among the highest of any cancer drug, puts the medicine at the center of a controversy over the growing cost of treating cancer. Monthly Price. (Bloomberg -- US)
